Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v3-EN
Language English English
Date Updated 2019-09-11 2019-07-05
Drug Identification Number 02167840 02167840
Brand name INNOHEP INNOHEP
Common or Proper name tinzaparin sodium tinzaparin sodium
Company Name LEO PHARMA INC LEO PHARMA INC
Ingredients TINZAPARIN SODIUM TINZAPARIN SODIUM
Strength(s) 10000UNIT 10000UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 10 x 2mL vials 10 x 2mL vials
ATC code B01AB B01AB
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-07-04 2019-07-04
Actual start date 2019-07-04 2019-07-04
Estimated end date 2019-08-30 2019-08-30
Actual end date 2019-09-10
Shortage status Resolved Actual shortage
Company comments
Health Canada comments